Actively Recruiting
Phase II Study of Pemetrexed for Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors Having Specific Gene Mutations
Led by Northwestern University · Updated on 2026-06-12
64
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how well the medication pemetrexed works in treating patients with metastatic urothelial bladder cancer and other metastatic solid tumors that have specific genetic mutations causing loss of function in the MLL4-proteinKMT2D-gene, UTX-proteinKDM6A-gene, or MTAP enzyme. These mutations are found in certain percentages of various cancers, and pemetrexed is being studied because it may interfere with tumor cell growth by blocking folic acid use in DNA production. This phase II trial aims to determine response rates and other outcomes in this patient group. Participants receive pemetrexed through an intravenous infusion lasting about 10 minutes on the first day of each 21-day cycle. Treatment continues as long as the disease does not progress and side effects remain acceptable. During the trial, patients undergo blood and urine sample collections and computed tomography CT scans. After completing treatment, participants have follow-up visits every three months for up to one year to monitor their health. Throughout the study, researchers assess how well the tumors respond to pemetrexed, including overall response rate, progression-free survival, overall survival, and duration of response, with evaluations conducted up to 12 months. Safety and tolerability are also closely monitored during treatment and for 30 days after the last dose. The trial collects plasma and urine samples for future studies on resistance mechanisms. Participation lasts through treatment and follow-up, involving scheduled scans, sample collections, and clinical assessments.
CONDITIONS
Brief Title
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
Research Team
S
Study Coordinator, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here